Sunshine Heart inks deal with Minnetronix for its C-Pulse implant system

Sunshine Heart (SSH -1.8%) announces a collaboration with St. Paul-based Minnetronix for a transcutaneous energy transfer system to power its C-Pulse device now under development.

The energy transfer system is used to power implanted devices - such as heart assist devices, artificial hearts and electrical stimulators - and enables power transfer across the skin using time varying magnetic fields without direct electrical connectivity.

The agreement includes milestone payments due to Minnetronix prior to U.S. regulatory approval for the fully-implantable C-Pulse system.

As previously announced, SSH intends to initiate animal studies for its fully-implantable pump in the fourth quarter of this year.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs